Strides Pharma Science Stock

Strides Pharma Science Liabilities

The The Liabilities of Strides Pharma Science (STAR.NS) as of Aug 7, 2026 is 34.97 B INR. In the previous year, The Liabilities was 37.14 B INR — a change of -5.85% (lower).

Liabilities

34.97 BINR

YoY

-5.85%

Last updated:

In 2026, Strides Pharma Science's total liabilities amounted to 34.97 B INR, a -5.85% difference from the 37.14 B INR total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Strides Pharma Science's Liabilities

Strides Pharma Science's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Strides Pharma Science's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Strides Pharma Science's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Strides Pharma Science's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Strides Pharma Science’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Strides Pharma Science stock

The Liabilities of Strides Pharma Science is 34.97 B INR in 2026.

The Liabilities of Strides Pharma Science changed from 37.14 B INR to 34.97 B INR, representing a -5.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Strides Pharma Science historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Strides Pharma Science

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Strides Pharma Science